STAT3 and neoplasm: Stat3 ablation in hematopoietic cells or treatment with CpG-Stat3 siRNA efficiently abolishes Stat3 activity in myeloid cells and B cells, leading to reduction of tumor burden and/or metastasis in mice [35], [36].